Fabbio Patrick — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Fabbio Patrick is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Profile

Fabbio Patrick

Patrick Fabbio is the Chief Financial Officer of Protara Therapeutics, Inc. (ticker: TARA) according to the most recent SEC filing dated 2026-01-21. The filing indicates no reported equity purchases or sales by the CFO during that period. Based on the SEC context, he leads the company's financial planning, accounting, and investor relations in support of Protara's focus on therapies for cancer and rare diseases.

RoleInsider
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-01-27TARAProtara Therapeutics, Inc.F — Tax withholding / forfeiture3.3K$6.67$22K
2026-01-22TARAProtara Therapeutics, Inc.F — Tax withholding / forfeiture3.1K$5.60$17K
2026-01-21TARAProtara Therapeutics, Inc.A — Grant or award28.0K$0.00

Frequently Asked Questions

Who is Fabbio Patrick?

Patrick Fabbio is the Chief Financial Officer of Protara Therapeutics, Inc. (ticker: TARA) according to the most recent SEC filing dated 2026-01-21. The filing indicates no reported equity purchases or sales by the CFO during that period. Based on the SEC context, he leads the company's financial planning, accounting, and investor relations in support of Protara's focus on ther…

Where can I see all of Fabbio Patrick's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Fabbio Patrick profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.